Molecular and cellular mechanisms of anthracycline cardiotoxicity. - Wikidata - awgldk - TriplyDB

Molecular and cellular mechanisms of anthracycline cardiotoxicity.

Molecular and cellular mechanisms of anthracycline cardiotoxicity.

http://www.wikidata.org/entity/Q36891743

about

Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure Perturbation of microRNAs in rat heart during chronic doxorubicin treatment Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity.The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.Anthracycline cardiotoxicity: from bench to bedside.ErbB signaling in cardiac development and disease.Cardiovascular effects in childhood cancer survivors treated with anthracyclines.Anthracycline-associated cardiotoxicity in survivors of childhood cancer.The role of neuregulin/ErbB2/ErbB4 signaling in the heart with special focus on effects on cardiomyocyte proliferation Sodium nitroprusside induces cell death and cytoskeleton degradation in adult rat cardiomyocytes in vitro: implications for anthracycline-induced cardiotoxicity.Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training Predicting and preventing the cardiotoxicity of cancer therapy.Myricitrin Protects against Doxorubicin-Induced Cardiotoxicity by Counteracting Oxidative Stress and Inhibiting Mitochondrial Apoptosis via ERK/P53 Pathway.Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes.HER2 breast cancer therapies: a review Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure.Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy.Cardiovascular effects of noncardiovascular drugs.Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.Effects of chemotherapy during pregnancy on the maternal and fetal heart.Cardiac toxicity of anticancer agents.Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failure.Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.Cancer chemotherapy and cardiac arrhythmias: a review.Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy.Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy.Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab.Chemotherapy-induced cardiotoxicity in children.Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity.Desferrioxamine attenuates doxorubicin-induced acute cardiotoxicity through TFG-β/Smad p53 pathway in rat model.The anthracyclines: when good things go bad.Chemotherapy-induced changes in cardiac capillary permeability measured by fluorescent multiple indicator dilution.

P2860

Q21134606-CBF9BD8F-7E49-41A5-B891-D07443E64B57 Q26778918-ED6910F1-1E1C-409C-8D52-D4943019BF11 Q26823592-4B34A52A-41E1-4FD9-97DF-7A5D131BBDFC Q27335046-B1551ECC-B38C-4EAC-A8CB-86AF60127C56 Q28083073-9E396F22-8529-4DBC-8FE9-81087B1AD182 Q33341069-AC47A810-5352-436C-BACB-89CC18A18342 Q33985016-5A051754-8D90-49AD-9136-CDB4B62C4809 Q34095827-40E33EFE-2FDE-4935-87D1-B5B4DD210090 Q34477415-E747B406-9790-4D7F-A703-13F677446693 Q34545577-EAF0952D-ECC6-4AA4-BA94-DEC95195CED3 Q34572109-E1082942-2943-4AA2-945C-DC96D8F5652F Q34626238-0AF07013-9789-467A-83E5-EC0599DF3FBF Q36042588-50644F53-69E2-496D-9556-B4D28DE79AC2 Q36193603-0A92C872-39ED-4AB9-944B-989DFF5113B5 Q36339976-7811B132-61E3-47F3-A495-339129DC1024 Q36568908-A046066B-5FDA-412B-B33F-660F5CF75853 Q36637796-3E87518C-669D-4BFC-99A8-F942F33CB099 Q36887091-C5872CC4-27F7-495B-B377-68C67B0E1525 Q37213203-447341E7-397E-45E8-B149-254A05C1B84C Q37230408-070547A4-32F9-422C-9256-F52A08C075D2 Q37290281-01340817-8179-47A5-871B-10DD0611086C Q37300632-3DD5FD80-2BC5-41C8-9828-8D3A76E9BF3C Q37303196-016A45A6-20DF-4BE2-A1AF-6693B34F21EB Q37341103-1B2D888E-A3A7-4F98-81A7-6C2CE9FFEC35 Q37375662-83FAFFDA-CA6E-4912-9FD5-9B1CE6D647B2 Q37413163-B8012B07-E03A-44E3-A75E-5FF265F3D108 Q37486763-88B8061F-7EEA-403A-816F-8CD5FE9E1906 Q38003095-57594787-4F86-4486-A8D5-88D19D8542FC Q38091377-A9AF5188-534C-4E60-828C-E26337087AF4 Q38200558-E49E7D6B-F6E8-4A83-905C-51B8B526383D Q38205702-2D7C7B89-A2BE-4F07-99B1-0B9D00C695D9 Q38313870-3BE0BB33-4062-47E9-A0F9-597FEA964AB6 Q38931763-7D82F3E7-23C3-4479-9E25-8B70E1793F4C Q39043233-2001D79C-B60B-4D44-B5D4-464DCFCD18D5 Q39344380-3B41C74E-CDDC-411E-9400-3BD835D25E19 Q39415815-0F53E7DB-4F21-4342-8A0A-D7A9EFD9D103 Q39608341-A8DEC6EE-EB81-454A-8FC7-3A0E9CB620E8 Q42138668-991BA516-8434-492B-B745-89FABDF44FE6 Q42163160-9B561CF3-96CB-4AEC-81F7-8012E22FE308 Q42550655-5D0B509E-1DE8-443E-BFAF-325700350EAE

P2860

Molecular and cellular mechanisms of anthracycline cardiotoxicity.

http://www.wikidata.org/entity/Q36891743

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Molecular and cellular mechanisms of anthracycline cardiotoxicity.

@en

type

label

Molecular and cellular mechanisms of anthracycline cardiotoxicity.

@en

prefLabel

Molecular and cellular mechanisms of anthracycline cardiotoxicity.

@en

P1433

Q36891743-EF22BBAD-89BD-471E-9159-94D37B62F88A

P1476

Q36891743-EF5C40E6-7893-4B83-A505-CE251BED1C2B

P2093

Q36891743-0A002090-99A6-4892-9A5B-680711F008AC

Q36891743-100F0512-1CCE-4458-907E-C4541AB1BAB9

Q36891743-AA15B151-25A8-4D3D-B86C-4B917E2B801A

Q36891743-C04E278C-C8AB-4D63-B75B-B37C3C0624FB

Q36891743-CD2FA461-9C13-4D41-BF18-C8AA299CDDD9

P2860

Q36891743-1B17D683-E276-4D58-8F2B-6E3E4F50C84D

Q36891743-4D7FF9FE-EE35-4199-B5CB-3CA0F93F4961

Q36891743-57D4C7B4-3D70-445F-AF0C-B3BF0946042D

Q36891743-583481B9-E62A-48EC-8B8A-F043D55DEFDC

Q36891743-721B86BE-7CF6-415A-A9BE-945177FC7E75

Q36891743-72EA3423-9DF2-4892-9C6B-DD2D0B7344E8

Q36891743-7A1E3DDE-EB92-4751-AEA3-C50A8C32F9B0

Q36891743-9993EAC3-E914-428E-A26F-B49093BE6513

P2888

Q36891743-69D813C1-61CA-4B0E-923A-23FB126B2BC1

P304

Q36891743-C0DE45E9-25AF-4D66-B18A-B533C0FE8785

P31

Q36891743-8CF77933-0CC6-4FD2-A14D-E173B8390AA5

P356

Q36891743-33649AB4-BE06-4FFA-AD90-05B17750092E

P433

Q36891743-73D593B0-D6C5-4D5A-8492-9476E3A893B4

P478

Q36891743-C1CD6D8F-E614-41C8-8817-5E8B6F03C428

P577

Q36891743-ABFDEBAA-F6A8-4E35-9DC4-6C76D3ADFCA5

P5875

Q36891743-298B2AD0-0B57-4384-BD2E-F5F44C714996

P698

Q36891743-C5EC9306-50A1-4A8C-B9CB-BAE0C7711195

P356

S12012-007-0005-5

P1433

Cardiovascular Toxicology

P1476

Molecular and cellular mechanisms of anthracycline cardiotoxicity.

@en

P2093

Billy Chen

http://www.w3.org/2001/XMLSchema#string

Chee Chew Lim

http://www.w3.org/2001/XMLSchema#string

Douglas B Sawyer

http://www.w3.org/2001/XMLSchema#string

Laura Pentassuglia

http://www.w3.org/2001/XMLSchema#string

Xuyang Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention

Transcriptional up-regulation of the mouse cytosolic glutathione peroxidase gene in erythroid cells is due to a tissue-specific 3' enhancer containing functionally important CACC/GT motifs and binding sites for GATA and Ets transcription factors.

Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis.

Doxorubicin selectively inhibits brain versus atrial natriuretic peptide gene expression in cultured neonatal rat myocytes.

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy.

Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.

Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo.

Some effects of daunomycin on the nucleic acid synthesis in synchronized L-cells.

P2888

s12012-007-0005-5

P304

114-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12012-007-0005-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6185611

http://www.w3.org/2001/XMLSchema#string

P698

17652815

http://www.w3.org/2001/XMLSchema#string